메뉴 건너뛰기




Volumn 369, Issue , 2020, Pages

Chloroquine and hydroxychloroquine in covid-19

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOQUINOLINE DERIVATIVE; ANGIOTENSIN CONVERTING ENZYME 2; CHLOROQUINE; HYDROXYCHLOROQUINE; PLACEBO; ANTIVIRUS AGENT;

EID: 85083284717     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.m1432     Document Type: Editorial
Times cited : (301)

References (29)
  • 1
    • 24944512442 scopus 로고
    • The theoretical basis of the sanocrysin treatment of tuberculosis
    • Moellgaard H. The theoretical basis of the sanocrysin treatment of tuberculosis. Br Med J 1925;1: 643-47. 10.1136/bmj.1.3353.643 20771993
    • (1925) Br Med J , vol.1 , pp. 643-647
    • Moellgaard, H.1
  • 2
    • 85083453058 scopus 로고
    • The gold treatment of tuberculosis
    • The gold treatment of tuberculosis. Br Med J 1925;1: 668. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2226411/pdf/brmedj05703-0025.pdf20772016
    • (1925) Br Med J , vol.1 , pp. 668
  • 3
    • 72849171445 scopus 로고
    • Severe infectious mononucleosis treated with chloroquine phosphate
    • Gothberg LA. Severe infectious mononucleosis treated with chloroquine phosphate. J Am Med Assoc 1960;173: 53-7. 10.1001/jama.1960.73020190016012 13851408
    • (1960) J Am Med Assoc , vol.173 , pp. 53-57
    • Gothberg, L.A.1
  • 4
    • 0014104484 scopus 로고
    • Infectious mononucleosis treated with chloroquine. A double-blind study of 40 cases
    • Updike SJ, Eichman PL. Infectious mononucleosis treated with chloroquine. A double-blind study of 40 cases. Am J Med Sci 1967;254: 69-70. 10.1097/00000441-196707000-00008 6027689
    • (1967) Am J Med Sci , vol.254 , pp. 69-70
    • Updike, S.J.1    Eichman, P.L.2
  • 6
    • 25444508979 scopus 로고    scopus 로고
    • Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
    • Vincent MJ, Bergeron E, Benjannet S, etal . Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005;2: 69. 10.1186/1743-422X-2-69 16115318
    • (2005) Virol J , vol.2 , pp. 69
    • Vincent, M.J.1    Bergeron, E.2    Benjannet, S.3
  • 7
    • 84873712360 scopus 로고    scopus 로고
    • Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model
    • Yan Y, Zou Z, Sun Y, etal . Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res 2013;23: 300-2. 10.1038/cr.2012.165 23208422
    • (2013) Cell Res , vol.23 , pp. 300-302
    • Yan, Y.1    Zou, Z.2    Sun, Y.3
  • 8
    • 85034590476 scopus 로고    scopus 로고
    • Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis
    • Shiryaev SA, Mesci P, Pinto A, etal . Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep 2017;7: 15771. 10.1038/s41598-017-15467-6 29150641
    • (2017) Sci Rep , vol.7 , pp. 15771
    • Shiryaev, S.A.1    Mesci, P.2    Pinto, A.3
  • 9
    • 85016471291 scopus 로고    scopus 로고
    • Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells
    • Li X, Burton EM, Bhaduri-McIntosh S. Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells. PLoS Pathog 2017;13: E1006249. 10.1371/journal.ppat.1006249 28249048
    • (2017) PLoS Pathog , vol.13 , pp. e1006249
    • Li, X.1    Burton, E.M.2    Bhaduri-McIntosh, S.3
  • 10
    • 85031102693 scopus 로고    scopus 로고
    • Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice
    • Li C, Zhu X, Ji X, etal . Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice. EBioMedicine 2017;24: 189-94. 10.1016/j.ebiom.2017.09.034 29033372
    • (2017) EBioMedicine , vol.24 , pp. 189-194
    • Li, C.1    Zhu, X.2    Ji, X.3
  • 11
    • 84955603527 scopus 로고    scopus 로고
    • Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo Guinea pig model
    • Dowall SD, Bosworth A, Watson R, etal . Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model. J Gen Virol 2015;96: 3484-92. 10.1099/jgv.0.000309 26459826
    • (2015) J Gen Virol , vol.96 , pp. 3484-3492
    • Dowall, S.D.1    Bosworth, A.2    Watson, R.3
  • 13
    • 85047499799 scopus 로고    scopus 로고
    • Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection
    • Roques P, Thiberville SD, Dupuis-Maguiraga L, etal . Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection. Viruses 2018;10: 268. 10.3390/v10050268 29772762
    • (2018) Viruses , vol.10 , pp. 268
    • Roques, P.1    Thiberville, S.D.2    Dupuis-Maguiraga, L.3
  • 14
    • 84929170755 scopus 로고    scopus 로고
    • Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery
    • Wang LF, Lin YS, Huang NC, etal . Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery. J Interferon Cytokine Res 2015;35: 143-56. 10.1089/jir.2014.0038 25321315
    • (2015) J Interferon Cytokine Res , vol.35 , pp. 143-156
    • Wang, L.F.1    Lin, Y.S.2    Huang, N.C.3
  • 15
    • 84879572897 scopus 로고    scopus 로고
    • Chloroquine use improves dengue-related symptoms
    • Borges MC, Castro LA, Fonseca BA. Chloroquine use improves dengue-related symptoms. Mem Inst Oswaldo Cruz 2013;108: 596-9. 10.1590/S0074-02762013000500010 23903975
    • (2013) Mem Inst Oswaldo Cruz , vol.108 , pp. 596-599
    • Borges, M.C.1    Castro, L.A.2    Fonseca, B.A.3
  • 16
    • 80051819215 scopus 로고    scopus 로고
    • Chloroquine for influenza prevention: A randomised, double-blind, placebo controlled trial
    • Paton NI, Lee L, Xu Y, etal . Chloroquine for influenza prevention: A randomised, double-blind, placebo controlled trial. Lancet Infect Dis 2011;11: 677-83. 10.1016/S1473-3099(11)70065-2 21550310
    • (2011) Lancet Infect Dis , vol.11 , pp. 677-683
    • Paton, N.I.1    Lee, L.2    Xu, Y.3
  • 17
    • 0020625123 scopus 로고
    • Disposition of chloroquine in man after single intravenous and oral doses
    • Gustafsson LL, Walker O, Alván G, etal . Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 1983;15: 471-9. 10.1111/j.1365-2125.1983.tb01532.x6849784
    • (1983) Br J Clin Pharmacol , vol.15 , pp. 471-479
    • Gustafsson, L.L.1    Walker, O.2    Alván, G.3
  • 18
    • 84979009448 scopus 로고    scopus 로고
    • Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity
    • Akpovwa H. Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity. Cell Biochem Funct 2016;34: 191-6. 10.1002/cbf.3182 27001679
    • (2016) Cell Biochem Funct , vol.34 , pp. 191-196
    • Akpovwa, H.1
  • 19
    • 85080879659 scopus 로고    scopus 로고
    • Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
    • Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020;14: 72-3. 10.5582/bst.2020.01047 32074550
    • (2020) Biosci Trends , vol.14 , pp. 72-73
    • Gao, J.1    Tian, Z.2    Yang, X.3
  • 20
    • 85083382067 scopus 로고    scopus 로고
    • Efficacy of hydroxychloroquine in patients with COVID-19: Results of a randomized clinical trial. Version 2
    • 03.22.20040758. [Preprint.]
    • Chen Z, Hu J, Zhang Z, et al. Efficacy of hydroxychloroquine in patients with COVID-19: Results of a randomized clinical trial. Version 2. medRxiv 2020.03.22.20040758. [Preprint.] 10.1101/2020.03.22.20040758
    • (2020) MedRxiv
    • Chen, Z.1    Hu, J.2    Zhang, Z.3
  • 21
    • 85083468005 scopus 로고    scopus 로고
    • Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19)
    • Yan D, Zhang Z. Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19). Chinese Clinical Trials Registry. http://www.chictr.org.cn/showproj.aspx? proj=48880
    • Chinese Clinical Trials Registry
    • Yan, D.1    Zhang, Z.2
  • 22
    • 85088375128 scopus 로고    scopus 로고
    • Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial
    • Gautret P, Lagier JC, Parola P, etal . Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020: 105949. 10.1016/j.ijantimicag.2020.105949 32205204
    • Int J Antimicrob Agents , vol.2020 , pp. 105949
    • Gautret, P.1    Lagier, J.C.2    Parola, P.3
  • 23
    • 85082979529 scopus 로고    scopus 로고
    • Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence
    • Lenzer J. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence. BMJ 2020;369: M1335. 10.1136/bmj.m1335 32238355
    • (2020) BMJ , vol.369 , pp. m1335
    • Lenzer, J.1
  • 25
    • 0034820122 scopus 로고    scopus 로고
    • Fatal toxic epidermal necrolysis associated with hydroxychloroquine
    • Murphy M, Carmichael AJ. Fatal toxic epidermal necrolysis associated with hydroxychloroquine. Clin Exp Dermatol 2001;26: 457-8. 10.1046/j.1365-2230.2001.00857-3.x11488840
    • (2001) Clin Exp Dermatol , vol.26 , pp. 457-458
    • Murphy, M.1    Carmichael, A.J.2
  • 26
    • 0028325972 scopus 로고
    • Fulminant hepatic failure secondary to hydroxychloroquine
    • Makin AJ, Wendon J, Fitt S, Portmann BC, Williams R. Fulminant hepatic failure secondary to hydroxychloroquine. Gut 1994;35: 569-70. 10.1136/gut.35.4.569 8175002
    • (1994) Gut , vol.35 , pp. 569-570
    • Makin, A.J.1    Wendon, J.2    Fitt, S.3    Portmann, B.C.4    Williams, R.5
  • 27
    • 85083451996 scopus 로고    scopus 로고
    • The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine/azithromycin
    • 04.02.20047050. [Preprint]
    • Chorin E, Dai M, Shulman E, et al. The QT interval in patients with SARS-CoV-2 infection treated with hydroxychloroquine/azithromycin. medRxiv 2020.04.02.20047050. [Preprint] 10.1101/2020.04.02.20047050v1
    • (2020) MedRxiv
    • Chorin, E.1    Dai, M.2    Shulman, E.3
  • 28
    • 59849098808 scopus 로고    scopus 로고
    • Survival after massive hydroxychloroquine overdose
    • Gunja N, Roberts D, McCoubrie D, etal . Survival after massive hydroxychloroquine overdose. Anaesth Intensive Care 2009;37: 130-3. 10.1177/0310057X0903700112 19157361
    • (2009) Anaesth Intensive Care , vol.37 , pp. 130-133
    • Gunja, N.1    Roberts, D.2    McCoubrie, D.3
  • 29
    • 84959338530 scopus 로고    scopus 로고
    • Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature
    • Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: A systematic review of the world literature. BMC Med 2016;14: 10. 10.1186/s12916-016-0553-2 26843061
    • (2016) BMC Med , vol.14 , pp. 10
    • Onakpoya, I.J.1    Heneghan, C.J.2    Aronson, J.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.